Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF).
about
Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8COPD and stroke: are systemic inflammation and oxidative stress the missing links?Pivotal roles of GM-CSF in autoimmunity and inflammationEffects of acrolein on leukotriene biosynthesis in human neutrophilsGlutathione peroxidase-1 primes pro-inflammatory cytokine production after LPS challenge in vivo.Selective targeting of nanocarriers to neutrophils and monocytes.Cytokine inhibition in the treatment of COPD.Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammationAnti-inflammatory effects of potato extract on a rat model of cigarette smoke-induced chronic obstructive pulmonary disease.Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.Physico-chemical characterization of African urban aerosols (Bamako in Mali and Dakar in Senegal) and their toxic effects in human bronchial epithelial cells: description of a worrying situation.The role of GM-CSF in adipose tissue inflammation.Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.Size-partitioning of an urban aerosol to identify particle determinants involved in the proinflammatory response induced in airway epithelial cells.Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPDThe granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.Targeted treatment in COPD: a multi-system approach for a multi-system disease.Recent advances in pre-clinical mouse models of COPD.The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models.Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.Oligonucleotides: a multi-targeted approach for the treatment of respiratory diseases.Glutathione peroxidase-1 as a novel therapeutic target for COPD.Autocrine effect of EGFR ligands on the pro-inflammatory response induced by PM(2.5) exposure in human bronchial epithelial cells.The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients.Role of size and composition of traffic and agricultural aerosols in the molecular responses triggered in airway epithelial cells.A flavanone from Baccharis retusa (Asteraceae) prevents elastase-induced emphysema in mice by regulating NF-κB, oxidative stress and metalloproteinasesAnti-inflammatory effects of antibacterials on human Bronchial epithelial cells.Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice.Neutralizing antibody against granulocyte/macrophage colony-stimulating factor inhibits inflammatory response in experimental otitis media.Imbalance of apoptosis and cell proliferation contributes to the development and persistence of emphysema.Hydrogen protects lung from hypoxia/re-oxygenation injury by reducing hydroxyl radical production and inhibiting inflammatory responses.Animal models of chronic obstructive pulmonary diseaseAssociation of Elevated Serum GM-CSF, IFN-, IL-4, and TNF- Concentration with Tobacco Smoke Induced Chronic Obstructive Pulmonary Disease in a South Indian Population
P2860
Q24303939-A26465AD-56D7-4981-A753-34CA2F53E74AQ26746530-18D82D05-70B1-4463-AF1B-58F2275F856CQ26830824-BB03F6C2-14A3-4F9E-AB81-E0A0D26F6471Q28750289-408E1EA5-09C8-425D-B22B-F2A5AD826BD4Q31050906-2C6F6884-92A1-4C6A-A7CD-DCECD471DE14Q33433964-5478CA1F-06B4-4F00-AD08-C448BF28E352Q33568552-3CB5A748-7B7B-4237-B85E-1E4420488255Q33702318-FFE853F0-2CE1-4043-B2E8-AE91FC7015E0Q36206448-5CC9B160-7B99-4720-B9CF-EC877EA43AF3Q36791049-F4E5DD12-E499-4B01-B83E-6CDF5A954AD0Q36798553-B4EBF45E-B89A-4CC1-AA84-1D86F0BC3A02Q36977013-763BC005-634B-41D7-9631-5C1FCCB77850Q37053851-A5CABC8B-A005-4F75-A25E-97701060A8C5Q37154623-1C526224-7F4E-436A-A767-F42A35C6648DQ37265525-BC73735E-DAD6-4783-8391-A4CF7FBC5C32Q37306641-DF74BB31-53E0-4126-9F57-95EE71DACA89Q37340178-38F37A81-020D-47A1-8E7E-8356A6052E10Q37426720-873C0461-9BFB-4DCA-AA6C-DAB40EE5385AQ37532493-1F0DF7CC-AB92-490B-B89B-AA747B7584FCQ37836078-9530AE79-CE75-44C9-B4C0-C6F4AA8FC38DQ37937557-F5E9A863-DF10-47EC-9A28-307D25CF280BQ38121222-8A008EF1-F100-4889-8B29-8C8D64F2609DQ39349014-BAE99D37-A8E9-4AEA-B21E-E47AC98FA30CQ39426025-977950B1-9D4F-4A18-897E-04E3AAF75941Q39481774-352480AE-9291-4B18-B55F-1D9730DDF2CEQ40785778-48CB8693-6156-4776-9997-F95C4813C16BQ42083447-CBF75FFC-DC3E-4462-A083-9E9799C57CEAQ43050665-DD36F1DD-40E6-478C-873F-3223FED83DCFQ44234732-C276A5E9-6B5F-44A4-8339-5561A0B0C1AEQ53211563-DCE61163-77D2-4B63-995F-E674D6EC7A39Q55226722-05337E27-3471-48FA-8AAE-789BA4DCFC69Q57097245-9EF35C37-871E-415C-9BF6-6596C38024BFQ58805864-246C1F16-848F-4EEA-BF6D-29EAD6315EE3
P2860
Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Therapeutic potential of treat ...... y stimulating factor (GM-CSF).
@ast
Therapeutic potential of treat ...... y stimulating factor (GM-CSF).
@en
type
label
Therapeutic potential of treat ...... y stimulating factor (GM-CSF).
@ast
Therapeutic potential of treat ...... y stimulating factor (GM-CSF).
@en
prefLabel
Therapeutic potential of treat ...... y stimulating factor (GM-CSF).
@ast
Therapeutic potential of treat ...... y stimulating factor (GM-CSF).
@en
P1476
Therapeutic potential of treat ...... ny stimulating factor (GM-CSF)
@en
P2093
P304
P356
10.1016/J.PHARMTHERA.2006.03.007
P577
2006-05-23T00:00:00Z